Myriad Genetics Launches the EndoPredict® Test in the United States for Patients with Breast Cancer

    NEXT STORY
    Tabula Rasa HealthCare to Present at the American Society for Clinical Pharmacology and Therapeutics Annual Meeting
    PREV STORY
    Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Matrix Medical Network puts a 40-foot Mobile Clinic into a 20-foot Exhibit Booth

    SCOTTSDALE, Ariz., March 07, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) has harnessed ...

    author_avatar
    NASDAQ Market News

    electroCore, Inc. Announces Additions to Board of Directors in Connection with Recently Completed Initial Public Offering

    BASKING RIDGE, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a ...

    author_avatar
    NASDAQ Market News

    iTeos Therapeutics Appoints Ann D. Rhoads to Board of Directors

    author_avatar
    NASDAQ Market News